Latest Breaking News On - Elodie dormes - Page 1 : comparemela.com

Vect-Horus Strengthens its Scientific Advisory Board with the Appointment of Dr. Julia Alterman

Vect-Horus, a biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, today announced the appointment of Julia Alterman

Vect-Horus and RadioMedix Announce FDA Approval of Exploratory IND of Diagnostic 68 Ga-RMX-VH in Glioblastoma Multiforme

Vect-Horus and RadioMedix Announce FDA Approval of Exploratory IND of Diagnostic 68 Ga-RMX-VH in Glioblastoma Multiforme

VECT-HORUS Completes Its €12 Million Fund-raising Operation

VECT-HORUS Completes Its €12 Million Fund-raising Operation VECT-HORUS, a biotech company that designs and develops vectors that enable therapeutic molecules or imaging agents to be delivered to key organs, has just closed its Series D fund-raising. The first round, held in September 2020, raised €6.7 million and a second round in December 2020 added €5.3 million from private investors, bringing the total amount raised in these two rounds to €12 million. This second funding round strengthens the company s capital so it can pursue its ambitious programmes, focusing on identifying new vectors, developing theragnostic (therapeutic and diagnostic) agents in a clinical setting and validating its technology for delivering therapeutic antibodies and nucleic acids.